Efficacy and Safety of Low Dose Rivaroxaban in Patients with Anterior Myocardial Infarction

Left Ventricular Thrombus in Myocardial Infarction Patients Treated with Successful Primary Percutaneous Coronary Intervention: Prevalence And Predictors

Effect of Low Dose NOACS (Rivaroxaban 2.5 mg Twice Daily) on Patients Who Underwent Complex Percutaneous Coronary Intervention

Incidence of Left Ventricular Thrombus and Embolic Phenomena in Patients with Acute Myocardial Infarction and Severe Left Ventricular Dysfunction

EFFICACY AND SAFETY OUTCOMES OF RIVAROXABAN IN ACUTE DEEP VENOUS THROMBOSIS PATIENTS

The Use of Direct Oral Anticoagulants Compared to Vitamin K Antagonists [Warfarin] in Patients with Left Ventricular Thrombus

XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa

Evaluation of CHA2DS2-VASc Score as a Predictor of Platelet Reactivity in Acute Myocardial Infarction Patients Treated by Percutaneous Coronary Intervention

Left Atrial Remodeling and short-Term Outcome in Patients Presenting with Non- ST Segment Elevation Myocardial Infarction

Comparative study of safety and effectiveness of rivaroxaban and warfarin in patients with acute deep venous thrombosis